A01K 2217/056
Due to mutation of coding region of the transgene
Official title: due to mutation of coding region of the transgene (dominant negative)
A01K2217/056 (Due to mutation of coding region of the transgene) appears on 56 US grants and 87 published applications in this corpus.
Search patents in A01K- Granted patents
- 56
- Published applications
- 87
- Assignees
- 54
- Inventors
- 149
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 4 |
| 2010 | 0 | 2 |
| 2011 | 2 | 5 |
| 2012 | 2 | 8 |
| 2013 | 2 | 3 |
| 2014 | 7 | 3 |
| 2015 | 4 | 3 |
| 2016 | 6 | 5 |
| 2017 | 3 | 5 |
| 2018 | 5 | 8 |
| 2019 | 2 | 7 |
| 2020 | 2 | 6 |
| 2021 | 6 | 7 |
| 2022 | 4 | 4 |
| 2023 | 6 | 5 |
| 2024 | 1 | 5 |
| 2025 | 2 | 1 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for modulating gene expression13 Jan 2026US 12,522,823 B2Flagship Pioneering Innovations V, Inc.
- Methods and compositions for modulating gene expression30 Dec 2025US 12,509,683 B2Flagship Pioneering Innovations V, Inc.
- Genetically modified rat models for severe combined immunodeficiency (SCID)15 Apr 2025US 12,274,247 B2Hera Testing Laboratories, Inc.
- Genetically modified mouse expressing human APOE4 and mouse Trem2 p.R47H and methods of use thereof16 Apr 2024US 11,957,115 B2Indiana University Research and Technology Corporation
- Genetically modified rat models for severe combined immunodeficiency (SCID)26 Dec 2023US 11,849,709 B2Hera Testing Laboratories, Inc.
- Methods and compositions for modulating gene expression6 Aug 2026US 2026/0226464 A1Flagship Pioneering Innovations V, Inc.
- Compositions and methods for the treatment of leukodystrophy and whole animal and cellular models for identifying efficacious agents for treatment of the same4 Jun 2026US 2026/0151513 A1The Children’s Hospital of Philadelphia
- Humanized immunodeficient mouse models26 Mar 2026US 2026/0083106 A1The Jackson Laboratory
- High-weight black soldier fly larvae, methods of producing same and use thereof12 Feb 2026US 2026/0041074 A1Freezem Cryogenics Ltd.
- Therapeutic nucleic acids and methods of use thereof23 Jan 2025US 2025/0025487 A1Cedars-Sinai Medical Center
Most cited
By later US patents
- Method of identifying compounds using a transgenic pig model of cystic fibrosis9US 7,989,675 B2The Curators of the University of Missouri · 2011
- Use of agonists and antagonists of IL-23 in the treatment of viral infection7US 8,263,080 B2Schering Corporation · 2012
- Methods and compositions for modulating gene expression6US 11,312,955 B2Flagship Pioneering Innovations V, Inc. · 2022
- Transgenic pig with altered incretin function6US 7,919,673 B2Ludwig-Maximilians-Universitat · 2011
- Transgenic pig model for a hereditary neurodegenerative autosomal dominant disease6US 8,173,861 B2Aarhus Universitet · 2012